01.20.10
A recent single blind, intra-individual study conducted by Dermscan Asia on 20 women in Thailand over a period of 84 days, showed that Slimaluma, from Gencor Nutrients, was effective in reducing the average volume of fat nodes, characterizing a significant anti-fat node effect.
Female subjects with Cellulitis on their thighs (age group 36 plus or minus 2 as mean) were treated with a cream containing 3% Slimaluma. The subjects acted as their own control, with placebo cream being applied on one part of the thigh and Slimaluma cream being applied on another part of the thigh. After 84 days of application the product showed a significant decrease in the average volume of the fat nodes on the spots applied, characterizing the anti-fat node effects of the product.
All the participants had reduction in fat nodes and the reduction in fat nodes was higher in the places where the Slimaluma cream was applied, compared to the places where the placebo cream was applied. This seems to suggest that the product has potential to reduce fat nodes by topical application.
The variations of the different parameters characterizing the fat nodes were studied by analysis of skin prints using PRIMOS Compact Phaseshift Rapid In-Vivo Measurement of Skin. Polymer Silicone skin prints (Siflo) were taken of the studied zones, before and at each time of measurement and studied using the PRIMOS 3D Compact. For further information: www.gencorpacific.com
Female subjects with Cellulitis on their thighs (age group 36 plus or minus 2 as mean) were treated with a cream containing 3% Slimaluma. The subjects acted as their own control, with placebo cream being applied on one part of the thigh and Slimaluma cream being applied on another part of the thigh. After 84 days of application the product showed a significant decrease in the average volume of the fat nodes on the spots applied, characterizing the anti-fat node effects of the product.
All the participants had reduction in fat nodes and the reduction in fat nodes was higher in the places where the Slimaluma cream was applied, compared to the places where the placebo cream was applied. This seems to suggest that the product has potential to reduce fat nodes by topical application.
The variations of the different parameters characterizing the fat nodes were studied by analysis of skin prints using PRIMOS Compact Phaseshift Rapid In-Vivo Measurement of Skin. Polymer Silicone skin prints (Siflo) were taken of the studied zones, before and at each time of measurement and studied using the PRIMOS 3D Compact. For further information: www.gencorpacific.com